Oncology Clinical Trials in Lake Success, NY
As of August 2026, 63 paid clinical trials are recruiting for Oncology in Lake Success, New York. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Lake Success
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
64 clinical trials for Oncology
·Clear filters·A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
A Study of PHST001 in Advanced Solid Tumors
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
A Phase 1 Study of the Safety and Tolerability of CTX-10726
A Study of GEN1106 in Participants With Solid Tumors
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
A Study of MGC026 in Participants With Advanced Solid Tumors
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Top Research Study Locations in Lake Success
Researchers run research studies in Lake Success, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Northwell Health/Center for Advanced Medicine | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Metastatic Renal Cell Carcinoma | 39 |
| Northwell Health | Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, 1st Line NSCLC | 16 |
| Northwell Health Cancer Institute | Acinar Cell Carcinoma, Advanced Cancer, Advanced Melanoma | 7 |
| Northwell Health/ RJ Zuckerberg Cancer Center | Neoplasm Metastasis, Advanced Solid Tumors, Carcinoma, Non-Small-Cell Lung | 6 |
| START New York | Advanced Solid Tumor, Advanced Solid Tumors, Endometrial Adenocarcinoma | 5 |
| GSK Investigational Site | Breast Neoplasms, Gastrointestinal Neoplasms, Neoplasms | 3 |
| Northwell Health Center for Advanced Medicine. | Colorectal Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer | 3 |
| Northwell Health -The Arthur Smith Institute for Urology | Intermediate Risk Non-Muscle Invasive Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ | 2 |
| Northwell Health Comprehensive Wound Healing Center | Chronic Wound of the Lower Limb (Leg Ulcer or Foot Ulcer), Vascular Disease, Peripheral, Venous Leg Ulcer (VLU) | 2 |
| Northwell Health Long Island Jewish Medical Center | Arterial Disease of Legs, Below-the-knee Obstruction, Chronic Limb-Threatening Ischemia | 2 |
| Northwell Health, LLC PRIME | AML, AML With Mutated NPM1, Acute Leukemia | 2 |
| Northwell Health, R.J. Zuckerberg Cancer Center | Advanced Melanoma, MF, Myelofibrosis | 2 |
| Northwell Health/R.J. Zuckerberg Cancer Center | Advanced Non-Small-Cell Lung Cancer, EGFR P-Loop and Alpha C-Helix Compressing, EGFR PACC | 2 |
| RJ Zuckerberg | Colorectal Cancer Metastatic | 2 |
| START New York Long Island | Head and Neck Squamous Cell Carcinoma, Advanced Solid Tumor, Cutaneous Squamous Cell Carcinoma | 2 |
| START New York Long Island LLC | Advanced or Metastatic Solid Tumor, Solid Tumors, Urothelial Carcinoma | 2 |
| START New York Long Island, LLC | Castration-resistant Prostate Cancer, Castration-resistant Prostate Cancer (CRPC), Colorectal Cancer | 2 |
| Ascendis Pharma Investigational Site | Idiopathic Short Stature, Short Stature Homeobox Gene Mutation, Small for Gestational Age at Delivery | 1 |
| Clincial Research | Non-healing Wound, Venous Insufficiency of Leg, Venous Leg Ulcer | 1 |
| Clinical Research Alliance, Inc | Small Cell Lung Cancer | 1 |
| Cohen Children's Medical Center | Cardiomyopathy | 1 |
| Cohen Children's Medical Center - Lakeville Road | Cystic Fibrosis | 1 |
| Cohen Children's Medical Center of NY | Crohn Disease | 1 |
| Cohen Children's Medical Center of New York | Rheumatic Joint Disease | 1 |
| Comprehensive Wound Healing Center, Northwell Health | Diabetic Foot Ulcer, Venous Leg Ulcer | 1 |
Active & Upcoming Studies in Lake Success (2026)
Recruiting trials in Lake Success grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (96 active studies)
- Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy · Phase 1, Phase 2 · Tubulis GmbH
- Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer · Phase 1 · Evopoint Biosciences Inc.
Diabetes & metabolic (2 active studies)
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events · Cleerly, Inc.
- DFC 004 Biomarkers for Active Diabetic Foot Ulcers · University of Michigan
Neurology & pain (2 active studies)
- Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS · Phase 2 · Vaneltix Pharma, Inc.
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Cardiovascular (1 active study)
- Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting · Philips Clinical & Medical Affairs Global
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Lake Success
- Advanced Solid Tumors (6 active studies)
- Colorectal Cancer (6 active studies)
- Head and Neck Squamous Cell Carcinoma (5 active studies)
- Acute Myeloid Leukemia (4 active studies)
- Advanced Solid Tumor (4 active studies)
- Endometrial Cancer (4 active studies)
Leading research sponsors in Lake Success
- National Cancer Institute (NCI)
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- Northwell Health
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Lake Success?
There are approximately 145 recruiting clinical trials in Lake Success, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lake Success pay participants?
Most recruiting trials in Lake Success compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lake Success?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lake Success?
The most common conditions under active study in Lake Success include Advanced Solid Tumors (6), Colorectal Cancer (6), Head and Neck Squamous Cell Carcinoma (5), Acute Myeloid Leukemia (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lake Success?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lake Success on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lake Success?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lake Success?
Recruiting research sites in Lake Success include Northwell Health/Center for Advanced Medicine, Northwell Health, Northwell Health Cancer Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lake Success right now?
The largest active categories in Lake Success are Cancer & tumors (96), Diabetes & metabolic (2), Neurology & pain (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.